JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Phibro Animal Health Corp

Cerrado

SectorSanidad

28.56 1.96

Resumen

Variación precio

24h

Actual

Mínimo

27.78

Máximo

28.72

Métricas clave

By Trading Economics

Ingresos

18M

21M

Ventas

39M

348M

P/B

Media del Sector

34.795

34.393

Rentabilidad por dividendo

1.84

Margen de beneficios

6.003

Empleados

1,940

EBITDA

26M

51M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+2.31% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.84%

2.54%

Próximas Ganancias

27 ago 2025

Fecha Próximo Dividendo

24 sept 2025

Próxima Fecha de Ex Dividendo

3 sept 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

107M

1.1B

Apertura anterior

26.6

Cierre anterior

28.56

Noticias sobre sentimiento de mercado

By Acuity

36%

64%

115 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Phibro Animal Health Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

11 ago 2025, 17:49 UTC

Principales Movimientos del Mercado

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11 ago 2025, 17:18 UTC

Principales Movimientos del Mercado

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11 ago 2025, 16:25 UTC

Ganancias

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11 ago 2025, 23:50 UTC

Charlas de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

11 ago 2025, 23:42 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

11 ago 2025, 23:42 UTC

Charlas de Mercado

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11 ago 2025, 23:36 UTC

Charlas de Mercado

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11 ago 2025, 23:32 UTC

Charlas de Mercado

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11 ago 2025, 23:02 UTC

Charlas de Mercado

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11 ago 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

11 ago 2025, 20:37 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11 ago 2025, 20:37 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Bakkt Holdings 2Q Rev $577.9M >BKKT

11 ago 2025, 20:37 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11 ago 2025, 20:22 UTC

Ganancias

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11 ago 2025, 20:22 UTC

Ganancias

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11 ago 2025, 20:22 UTC

Ganancias

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11 ago 2025, 20:22 UTC

Ganancias

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11 ago 2025, 20:22 UTC

Ganancias

Exodus Movement 2Q Rev $25.8M >EXOD

11 ago 2025, 20:14 UTC

Charlas de Mercado

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11 ago 2025, 19:12 UTC

Charlas de Mercado

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11 ago 2025, 18:56 UTC

Charlas de Mercado

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11 ago 2025, 18:31 UTC

Charlas de Mercado

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11 ago 2025, 17:43 UTC

Charlas de Mercado

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11 ago 2025, 17:28 UTC

Charlas de Mercado

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11 ago 2025, 17:16 UTC

Charlas de Mercado

Commodity Longs Fall to 11-Month Low -- Market Talk

11 ago 2025, 16:42 UTC

Adquisiciones, fusiones, absorciones

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11 ago 2025, 16:27 UTC

Adquisiciones, fusiones, absorciones

BBVA Says Sabadell Offer Remains in Effect

11 ago 2025, 16:26 UTC

Adquisiciones, fusiones, absorciones

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11 ago 2025, 16:25 UTC

Adquisiciones, fusiones, absorciones

Banco de Sabadell Announced TSB Sale on July 1

11 ago 2025, 16:25 UTC

Adquisiciones, fusiones, absorciones

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Comparación entre iguales

Cambio de precio

Phibro Animal Health Corp previsión

Precio Objetivo

By TipRanks

2.31% repunte

Estimación a 12 Meses

Media 28.75 USD  2.31%

Máximo 35 USD

Mínimo 24 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Phibro Animal Health Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

1

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

17 / N/ASoporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

115 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.